Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03498248Not ApplicableUnknown

Efficacy of Granulocyte-Colony Stimulating Factor (G-CSF)

Role: lead

NCT03117075Not ApplicableUnknown

The Efficacy of Pain Management With Self-reporting Pain Monitoring System in Cancer Patient

Role: lead

NCT02516371Not ApplicableUnknown

Lymphocytes Subpopulation in Cancer Patients

Role: lead

All 3 trials loaded